A study has added to the growing body of evidence that remission of type 2 diabetes may be achieved with aggressive lifestyle changes. DiRECT-Aus set out to determine if a 12-month intervention, incorporating low-energy total diet replacement (TDR), could induce remission in adults with recently diagnosed type 2 diabetes in an Australian primary care setting.
The open-label, single-arm intervention trial recruited adults aged 20–65 years with type 2 diabetes duration of ≤6 years, with HbA1c at entry ≥6.5% (≥48 mmol/mol), BMI >27.0 kg/m2 and who were not treated with insulin. At baseline, there were equal numbers of males and females, with mean age of 52.5 years, weight of 106.9 kg, BMI of 37.7 kg/m2, HbA1c of 7.1% (54 mmol/mol) and type 2 diabetes duration of 2.8 years. Glucose-lowering medications were used by 88%.
Participants (n=155) underwent a 13-week TDR (800–950 kcal, depending on BMI), with fortnightly dietitian visits. This was followed by an 8-week structured food reintroduction and 31 weeks of supported weight management. An increase in daily physical activity was also encouraged, with a target of 15,000 steps.
At 12 months, 86 (56%) of participants had achieved type 2 remission (defined as HbA1c <6.5% [<48 mmol/mol] and off glucose-lowering medications for ≥2 months ± 7 days). The number was highest at the end of the TDR phase at 102 (66%), with 99 (64%) and 92 (90%) at 6 and 9 months, respectively.
Across all of the participants, the mean adjusted weight loss after the TDR was 11.2% (95% CI, 10.3–12.1). At 12 months, it was 8.1% (7.2–9.1). The likelihood of remission was proportional to weight loss, with remission being achieved by 87% of participants who reduced their weight by >15%. The TDR was well tolerated, with only a few serious adverse events that were largely related to hypotension.
Following an intensive lifestyle intervention delivered in primary care, the rate of remission of type 2 diabetes of around one in two participants was similar to the findings of both the DiRECT and DIADEM-I trials, despite being conducted in different countries and across different ethnicities. The investigators conclude that a low-energy TDR is a robust intervention for type 2 diabetes remission, particularly if adopted within 6 years of diagnosis.
The full study findings can be read here.
Journal of
Diabetes Nursing
Issue:
Early View
Type 2 diabetes remission with low-energy diet
A study has added to the growing body of evidence that remission of type 2 diabetes may be achieved with aggressive lifestyle changes. DiRECT-Aus set out to determine if a 12-month intervention, incorporating low-energy total diet replacement (TDR), could induce remission in adults with recently diagnosed type 2 diabetes in an Australian primary care setting.
The open-label, single-arm intervention trial recruited adults aged 20–65 years with type 2 diabetes duration of ≤6 years, with HbA1c at entry ≥6.5% (≥48 mmol/mol), BMI >27.0 kg/m2 and who were not treated with insulin. At baseline, there were equal numbers of males and females, with mean age of 52.5 years, weight of 106.9 kg, BMI of 37.7 kg/m2, HbA1c of 7.1% (54 mmol/mol) and type 2 diabetes duration of 2.8 years. Glucose-lowering medications were used by 88%.
Participants (n=155) underwent a 13-week TDR (800–950 kcal, depending on BMI), with fortnightly dietitian visits. This was followed by an 8-week structured food reintroduction and 31 weeks of supported weight management. An increase in daily physical activity was also encouraged, with a target of 15,000 steps.
At 12 months, 86 (56%) of participants had achieved type 2 remission (defined as HbA1c <6.5% [<48 mmol/mol] and off glucose-lowering medications for ≥2 months ± 7 days). The number was highest at the end of the TDR phase at 102 (66%), with 99 (64%) and 92 (90%) at 6 and 9 months, respectively.
Across all of the participants, the mean adjusted weight loss after the TDR was 11.2% (95% CI, 10.3–12.1). At 12 months, it was 8.1% (7.2–9.1). The likelihood of remission was proportional to weight loss, with remission being achieved by 87% of participants who reduced their weight by >15%. The TDR was well tolerated, with only a few serious adverse events that were largely related to hypotension.
Following an intensive lifestyle intervention delivered in primary care, the rate of remission of type 2 diabetes of around one in two participants was similar to the findings of both the DiRECT and DIADEM-I trials, despite being conducted in different countries and across different ethnicities. The investigators conclude that a low-energy TDR is a robust intervention for type 2 diabetes remission, particularly if adopted within 6 years of diagnosis.
The full study findings can be read here.
Digital eye screening to be available in the community
Case study: Newly diagnosed type 1 diabetes education given to families with learning disabilities
Improving diabetes foot care for people with dark skin tones
The role of the diabetes specialist midwife
The GIRFT return on investment tool and the role of diabetes inpatient specialist nurses
What’s hot in diabetes nursing? November 2024
Diabetes specialist nurses’ insights on an in-reach service project for people with diabetes on dialysis: Evaluating impact and outcomes
Plans announced to provide appointments outside of hospital setting
29 Nov 2024
Identifying additional needs, applying appropriate teaching and providing appropriate support.
28 Nov 2024
New handbook for healthcare professionals aims to improve outcomes
21 Nov 2024
How this broad and challenging work impacts on diabetes care.
21 Nov 2024